Brian Safina PhD

Brian Safina, Ph.D., serves as Vice President, Medicinal Chemistry & Bioconjugation for Bolt Biotherapeutics. He joined Bolt in 2018 with over 14 years of experience in large pharma and has made contributions in multiple therapeutic areas including oncology, immunology, and neuroscience. Prior to Bolt, Dr. Safina was at Genentech where he served in roles of increasing responsibility in Discovery Chemistry, which included serving as a project team leader for early and late-stage projects with 30+ team members. He has published over 25 papers and is named on over 25 granted patents and more than 10 patent applications. Dr. Safina holds a Ph.D. in organic chemistry from the University of California, San Diego.